Metraipolis › archive › dc_fbc616f65bd3

Characteristics and risk factors of immune-related adverse events in patients receiving immune checkpoint inhibitor combination therapy — Europe PMC PMID:42294346

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42294346
DOI
10.3389/fonc.2026.1808832
License (as archived)
solo-consultazione
Archived
2026-11-01T02:18:51.967Z
SHA-256 of the archived text
2e21912b1872c1efdf2a2d3aeb7a1e55263ae956d1199d6ff21899dbdc8b8fb6
Stable URL of this page
https://metraipolis.com/documento/dc_fbc616f65bd3

How to cite

Characteristics and risk factors of immune-related adverse events in patients receiving immune checkpoint inhibitor combination therapy — Europe PMC PMID:42294346 — Europe PMC (en), https://europepmc.org/article/MED/42294346 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_fbc616f65bd3 (Metraipolis archive dc_fbc616f65bd3, sha256 2e21912b1872c1efdf2a2d3aeb7a1e55263ae956d1199d6ff21899dbdc8b8fb6)
BibTeX
@misc{dcfbc616f65bd3,
  title = {Characteristics and risk factors of immune-related adverse events in patients receiving immune checkpoint inhibitor combination therapy — Europe PMC PMID:42294346},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42294346},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_fbc616f65bd3; sha256 2e21912b1872c1efdf2a2d3aeb7a1e55263ae956d1199d6ff21899dbdc8b8fb6},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42294346. Agents can read the archived copy with the MCP tool read_document.